| Revenue growth | 6% YoY overall; B2C revenue grew 18%. |
|---|---|
| Margins | EBITDA margin expanded 320 bps to 37.5%. |
| Order book | B2B network expanded to 100+ hospital tie-ups. |
| Demand visibility | Strong PPP-based radiology demand in Uttar Pradesh. |
Growth
EBITDA grew 17% to ₹33.2cr; PAT margin expanded to 21.8% driven by operating leverage.
Outlook
Management guides 25-30% YoY growth; new Dwarka center operational by H1 FY27; adding 4 more tie-ups.
Risks
High reliance on B2G/PPP segments (54% of revenue) and geographic concentration in Delhi and UP.
Earnings Call filed with BSE, BSE: 544482. Summary written with AI assistance from the document.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹77.70
- Market cap
- ₹135.3 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 7.0×Sector 57.8×
- Promoter holding
- 71.92%
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab Earnings Call: Key Takeaways
Star Imaging reported FY26 revenue of ₹88.5cr (up 6%) and PAT of ₹19.3cr (up 21%). Management focuses on B2C expansion and becoming debt-free.
Star Imaging and Path Lab Earnings Call: Key Takeaways
Star Imaging reported steady FY26 growth despite regulatory delays in new centers. Management shifted focus to FY27, banking on a capacity ramp-up and improved government receivables to drive momentum.
Star Imaging and Path Lab H2 FY26 Results: Net Profit ₹9.2 Cr, Down 5.2% YoY
Star Imaging and Path Lab Ltd reported revenue from operations of ₹43.3 Cr (+5.9% YoY) and net profit of ₹9.2 Cr (-5.2% YoY) for H2 FY26.
- Key figure
- Net profit ₹9.2 Cr · -5.2% YoY